companydata.dkNOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2023
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1 and a net result of DKK 261,035,112 compared with DKK 132,670,108 the year before. Equity amounted to DKK 1,034,522,882. The solvency ratio was 99.7%.
- Gross Profit
- 1 kr.
- Profit/Loss
- 261,035,112 kr.
- Equity
- 1,034,522,882 kr.
- Total Assets
- 1,037,961,976 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1 | 261 mio. | 1 mia. | - |
| 2022 | - | -1 | 132.7 mio. | 903.5 mio. | 0 |
| 2021 | - | -33 t. | 56.1 mio. | 828.8 mio. | 0 |
| 2020 | - | -32 t. | 45.6 mio. | 817.8 mio. | 0 |
| 2019 | - | -38 t. | 283.5 mio. | 1.1 mia. | 0 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 2, 2023, Rainer Chapour Lehmann has joined the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
As of November 2, 2023, Lars Green has left the board of directors of NOVOZYMES BIOINDUSTRIAL CHINA A/S.
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2022. Gross profit came to DKK -1, and the net result was DKK 132,670,108.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.